Investing in shared sustainable success
As a family-owned global company we think in generations rather than in quarters. We are firmly committed to the animal health industry and strive to deliver value through innovation to you for years to come.
1 Ames (USA) R&D + Diagnostics
2 Fort Dodge (USA) R&D + Production
3 Guadalajara R&D + Production
4 Sioux (USA) R&D
5 St Joseph (USA) R&D + Production
6 Weesp (Netherlands) R&D + Production
7 Hanover (Germany) R&D + Diagnostics
8 Ingelheim (Germany) Head office
9 Shanghai Taitzu (China) R&D + Production
Boehringer Ingelheim's unparalleled investment in research and development means that our extensive expertise in vaccination and swine health is augmented by state-of-the-art diagnostic technology at our global diagnostic centres. Our global experts in research and development are located in nine research facilities in five countries on three continents. This keeps us at the forefront in the identification of new and increasingly troubling pathogens.
